Table Of Content

index to Volume 39 January 609-712 February 713-808 September . 869-920 297-392 October 921-1008 393-504 November 1009-1128 ee 505-608 December 1128-1224 & detection of, 697 Amaryl. See Glimepiride Abarelix (Plenaxis), 172, 264, 368 and drug market removal, 1138 Amerge. See Naratriptan review of, 628 epidemiology of, 697 Amicar. See Aminocaproic acid Abbreviations, acronyms, and symbols information on, sources of, 697 Amifostine (Ethyol), caer with, 207 prohibited, 427 preventable, 648 Amino acid 8% injection (HepatAmine), “QD,” 589 reporting requirements, 697, 1138 warning related to, 800 reports on, call for, 856 Amino acids with dextrose (Clinimix—Sulfite Abciximab (ReoPro) versus eptifibatide, in percutaneous reviews of, 1152 Free), warning related to, 489 coronary intervention, 661 risk factors for, 697 Amino acids with electrolytes in dextrose warning related to, 372 terminology for, 624 with calcium (Clinimix E-Sulfite Free Abetimus (Riquent), 1097, 1197, 1200 transfer between acute and long-term care Injection), warning related to, 489 Abilify. See Aripiprazole facilities and, 407 Aminocaproic acid (Amicar) Abraxane. See Paclitaxel, nanoparticle Advertising, direct-to-consumer, of prescrip- oral liquid, sorbitol content of, 225 Abstracts, writing, guidelines for, 289 tion drugs, 1058 warning related to, 1202 Acamprosate (Campral), 1089, 1192, 1186 Agenerase. See Amprenavir Aminoglycosides, for elderly, once-daily review of, 1177 Aggrenox. See Aspirin/dipyridamole administration of, 238 Accolate. See Zafirlukast Agitation, management of, olanzapine for Amiodarone (Cordarone) Accountability, new models of, 515 injection (intramuscular) for, 776, 783 hepatic monitoring with, 596 Accupril. See Quinapril Albendazole (Albenza), hepatic monitoring warning related to, 892 Accuretic. See Quinapril/hydrochlorothiazide with, 604 Amlodipine/atorvastatin (Caduet), 364, 482, Accutane. See Isotretinoin Albenza. See Albendazole 572, 684 Aceon. See Perindopril Albumin, computerized prescriber order Amlodipine besylate/benazepril hydrochlo- Acetadote. See Acetylcysteine entry for, 1106 ride (Lotrel), warning related to, 1202 Acetaminophen (Tylenol) Aldara. See Imiquimod Amphetamine salts (Adderall XR), warning hepatic monitoring with, 604 Alemtuzumab (Campath), warning related related to, 1202 oral liquid, sorbitol content of, 225 to, 892 Amphotericin B Acetylcysteine (Acetadote, Mucomyst), 364, Alendronate (Fosamax), CNS disturbances computerized prescriber order entry for, 478, 572, 683 with, 730 1106 dosage forms, confusion between, 1020 Aleve. See Naproxen stability, and treatment of coccidioidal intravenous, 568 Alfuzosin (Uroxatral) meningitis, 554 review of, 564 and Oxytrol, confusion of, 1021 Amprenavir (Agenerase), hepatic monitoring and Mucinex, confusion of, 820 and Roxanol, confusion of, 1021 with, 601 Acquired immunodeficiency syndrome Alimta. See Pemetrexed Anakinra (Kineret), drug information, errata (AIDS). See HIV-infected (AIDS) Allegra-D. See Fexofenadine/ in, 403 patients pseudoephedrine Anal fissures, topical sildenafil for, 1160 Acronyms. See Abbreviations, acronyms, and Allergy Anaphylaxis symbols to generics, 830 acute ischemic colitis caused by, 730 Actidose w/sorbitol. See Charcoal, activated to soy, 1141 cause of, 312 Actiza. See Clindamycin Allopurinol, and azathioprine, interactions incidence of, 312 Actonel. See Risedronate of, 648 severity of, 312 Actos. See Pioglitazone Almotriptan (Axert), warning related to, Anaprox. See Naproxen Acute respiratory distress syndrome, corti- 1100 AndroGel. See Testosterone gel costeroids for, 116 Alopecia areata, with infliximab, 1026 Angeliq. See Estradiol/drospirenone Acyclovir (Zovirax), cream, and Zostrix Alora. See Estradiol Angiomax Injection. See Bivalirudin cream, confusion of, 11 Alprazolam, kava kava and, interactions of, Angiotensin-converting enzyme inhibitors, Adalimumab (Humira), 1093 149 pancreatitis caused by, 1149 warning related to, 1100 Altace. See Ramipril Angiotensin II receptor blockers, fingernail Adderall XR. See Amphetamine salts; Dex- Altocor. See Lovastatin clubbing and discoloration with, 525 troamphetamine and amphetamine Altocor Extended-Release Tablets. See Anidulafungin, 794, 886, 1094, 1197 Adefovir dipivoxil (Hepsera), warning relat- Lovastatin Anorgasmia with bupropion, 828 ed to, 1202 Aluminum hydroxide gel, oral liquid, Anthelmintics, adverse drug reactions with, Advair. See Fluticasone/salmeterol sorbitol content of, 225 407 Advair Diskus. See Fluticasone/salmeterol Aluminum hydroxide/magnesium carbonate Antibiograms, 92, 188 Adverse drug-related events (ADRs) (Gaviscon), oral liquid, sorbitol content clinical applications of, 542 in ambulatory older adults, 24 of, 225 development of, 542 anthelmintic-related, 407 Aluminum hydroxide/magnesium hydroxide NCCLS guidelines, 542 causality, 697 (Maalox, Maalox TC), oral liquid, sor- Antibiotics, shortage of, pharmacoeconomics classification of, 697 bitol content of, 225 of, 43 clinical analysis of, 697 Alvimopan (Entereg), 690, 797, 889, 1097, Anticoagulation therapy clinical evaluation of, 697 1200 alternatives to heparin in, 410 in clinical trials, detection of, 697 Amantadine (Symmetrel) warfarin for, 414 costs of, 648 oral liquid, sorbitol content of, 225 Antidepressants. See also Selective serotonin definition of, 697 warning related to, 372 reuptake inhibitors 1212 Volume 39, December 2004 Indetxo Volum3e8 hypertensive crisis with, 114 multidose pediatric oral liquid antibiotics, Avandamet. See Rosiglitazone/metformin Antifungal 280 Avandia. See Rosiglitazone taste disturbance with, 351 multiple doses, 378 Avastin. See Bevacizumab thrombocytopenia caused by, 1148 night cabinet stock, 282 Avelox. See Moxifloxacin Anti-infective agents, intravenous to oral night cabinet use, 181 Axert. See Almotriptan conversion programs for, 1069 nonformulary medication, 80, 81 Azacitidine (Vidaza), 268, Antimicrobial resistance, in respiratory on-call pharmacist, 282 690, 786, 880 pathogens, 1050 order review by nursing supervisor, 377 Azathioprine (Imuran Antimicrobial stewardship program, develop- pain management standards, 79 and allopurinol, interactions of, 648 ment of, at pediatric hospital, 317 partial dosing, 378 hepatic monitoring with, 604 Antipsychotics, and sudden cardiac death, patient assistance programs, 78 Azelastine hydrochloride (Astelin Ready- 828 pharmacist review of orders Spray), 687, 793 Apidra. See Insulin glulisine for contrast media, 375 Azithromycin (Zithromax), 369, 484 Apokyn. See Apomorphine hydrochloride and floor stock, 180 Apomorphine hydrochloride (Apokyn), 683, for multiple treatments, 377 792, 880 and off-site clinics, 376 BabyBIG. See Botulism immune globulin Arava. See Leflunomide in phase II recovery area, 182 intravenous, human Arcoxia. See Etoricoxib time frame for, 180 Bar code medication administration, PDA Argatroban preprinted order forms, 180 interface and, 386 dosage and administration of, 410 prescribers’ handwriting, 375 Basic Bibliographies for heparin-induced thrombocytopenia, PRN doses of IV drugs for pediatric antibiograms, 92, 188 414 patients, 278 black box drug warnings, 293 Aricept. See Donepezil radiopharmaceuticals, 182, 375 blood transfusions: alternatives, 591 Ariflo. See Cilomilase refrigerator temperatures, 79 collaborative practice: physicians and Arilvax. See Yellow fever vaccine renew orders, 179 pharmacists, 189 Aripiprazole (Abilify), 1194 respiratory therapy drugs, 182, 376 correctional facilities: health care and warning related to, 800 resume orders, 179 pharmacy, 896, 1211 Arixtra. See Fondaparinux sodium sample drug documentation, 80 gemcitabine: off-label uses, 499 Artane. See Trihexyphenidy] standard MM.1.10, 80 geriatrics: appropriate medication use, 294 Ask the Joint Commission standard MM.2.10, 80, 380 hot flashes, 898 access to pharmacy after hours, 282, 284 standard MM.2.20, 79, 81 hypertension, 592 after-hours dispensing, 282, 284 standard MM.2.30, 83 ae of, 1208 anesthetic agents, 78 standard MM.2.40, medical news columns, 294 automatic stop orders, 79 standard MM.3.10, myasthenia gravis, 389 computerized physician order entry, 181 standard MM.3.20, nebulized opioids for management of dys- contracted pharmacy services, 380 standard MM.4.10, pnea, 920 contrast agents, 182, 183 380 neonatal abstinence syndrome, 500 definition "limited area," 378 standard MM.4.20, neonatal parenteral nutrition, 502 definition of compounding, 378 standard MM.4.30, patent ductus arteriosus: ibuprofen thera- definition of IV admixture, 378 standard MM.4.40, py, 390 definition of "medication," 376 standard MM.4.50, ; pediatrics: neuromuscular blocking drugs, definition of "qualified health care standard MM.4.70, 189 professional," 181, 376, 377, 378 standard MM.5.10, : pharmaceutical care, in Japan, 94 definition of "readily accessible" standard MM.6.10, pharmacy newsletters, 594 information, 80 standard MM.7.10, practice guideline implementation, 94 discontinued medications, 80 prescribing by pharmacists, 390 documentation requirements, 80, 178, 181 storage of concentrated electrolytes, 81, Beers List, updating, 210 drug information oe nurses, 79 82 Benadryl Fastmelt, soy protein ingredient in, drug recall, notification of patient about, syringes, drawing up, 278, 377 1141 380 transcription of medication orders by unit Benazepril (Lotensin), warning related to, emergency medication security, 83 secretaries, 79 270 emergent administration of IV admixtures, transfer of medications, 79 Benazepril/hydrochlorothiazide (Lotensin 279 unit-dose medications, 280, 281, 378 HCT), warning related to, 270 floor stock, 180, 281 vaccine labeling, 280 Benign prostatic hyperplasia, formulary con- formulary's list of drugs, 81 verbal orders, 79, 179 version from doxazosin to terazosin high-risk/high-alert drug identification, weight and height data, 80 for, 47 380 Aspirin, 73, 175, 268 Benzocaine, methemoglobinemia with, 830 high-risk/high-alert drug storage, 285 Aspirin/dipyridamole (Aggrenox), warning Beractant, computerized prescriber order investigational drugs, 380 related to, 489 entry for, 1106 IV admixtures, 278, 279, 377, 378 Astelin Ready-Spray. See Azelastine Beta-blockers, selective, for hemodialysis IV pitocin and magnesium sulfate, 377 hydrochloride patients, 144 labeling requirements, 278, 280, 380 Atacand. See Candesartan cilexetil 17-Beta-estradiol (Estrasorb), 71, 173, 264 licensed jidepalen practitioner (LIP), ~ Arazanavir (Reyataz) Betaseron. See Interferon-beta-1b 181 lipid levels with, 1152 Bevacizumab (Avastin), 478, 573, 686 look-alike and sound-alike drugs, 82, 83 warning related to, 578 review of, 747 magnesium sulfate 50%, storage of, 82 Atenolol/clorthalidone (Tenorectic), warning § Bexxar. See Tositumomab medication administration times, 380 related to, 270 Bipolar disorder, mania, agitation in, olanza- medication management standards for Atorvastatin (Lipitor), 1093 pine for, 776 2004, 78, 178, 278 dosage and administration of, 52 Bisphosphonates, CNS effects of, 730 application of, 285 hepatic monitoring with, 595 Bivalirudin (Angiomax Injection) medication monitoring8,1 polyneuropathy caused by, 16 dosage and administration of, 410 "medication override" function in auto- Atrial fibrillation, rhythm control versus rate for heparin-induced thrombocytopenia, mated dispensing, 181 control in, 17 414 medications brought from home, 80, 83, Atropine (AtroPen), warning related to, 74 warning related to, 893 285, 380 Auranofin (Ridaura), hepatic monitoring Black box drug warnings, 293 monitoring new medications, 284 with, 598 Bladder cancer Hospital Pharmacy 1213 Index to Volume 38 intravesical mitomycin:for, 1031 Caspofungin (Cancidas), thrombocytopenia Clodronate (Bonefos), 1097, 1200 superficial, intravesical gemcitabine for, caused by, 1148 Clofarabine, 74, 176, 269, 488, 796, 889, 1153 Cefdinir (Omnicef), 1193 1097, 1198, 1200 Blood transfusions, alternatives to, 591 Cefotan. See Cefotetan Clopidogre} (Plavix), thrombotic thrombocy- Bonefos. See Clodronate Cefotetan (Cefotan), warning related to, 74 topefiic purpura caused by, 627 Boniva. See Ibandronate sodium Celebrex. See Celecoxib Clozapine (Clozaril, Fazaclo), 478, 574, 686, Bosencan (Traclear), hepatic monitoring Celecoxib (Celebrex) 792 with, 602 hepatic monitoring with, 600 warning related to, 489 Botox. See Botulinum toxin type A pulmonary edema with, 730 Clozaril. See Clozapine Botulinum toxin type A (Botox), 1093 Celexa. See Citalopram Coccidioides immitis, meningitis caused by, Botulism immune globulin intravenous, Celontin. See Methsuximide treatment of, amphotericin B stability human (BabyBIG), 475 Cenestin. See Estrogens, conjugated and, 554 review of, 470 Central nervous system, alendronate and, Coenzyme Q10, and warfarin, interactions Bromfenac sodium (Xibrom), 796, 889, 730 of, 149 1097, 1200 Certican. See Everolimus Cognex. See Tacrine Bupropion (Wellbutrin, Wellbutrin SR, Well- Cetirizine (Zyrtec), 483, 574, 687 Cognitive impairment, statin-related, 112 butrin XL, Zyban) hepatitis caused by, 1149 Colitis, acute ischemic, caused by anaphylac- anorgasmia with, 828 Cetrorelix acetate (Cetrotide), warning tic reaction, 730 warning related to, 578, 893 related to, 800 Collaborative practice, physicians and phar- C Cetrotide. See Cetrorelix acetate macists, 189 Cetuximab (Erbitux), 367, 483, 573, 686 Combidex. See Ferumoxtran-10 Caduet. See Amlodipine/atorvastatin review of, 750 CombiPatch. See Estradiol/norethindrone Caffeine citrate, computerized prescriber Charcoal, activated (Actidose w/sorbitol), acetate transdermal system order entry for, 1106 oral liquid, sorbitol content of, 225 Communication, computerized prescriber Calcimimetic, cinacalcet hydrochloride as, Chemet. See Succimer order entry decision support tools and, 666, 678 Chemoembolization, transcatheter arterial, 1106 Calcium-DPTA. See Pentetate calcium disodi- for hepatocellular carcinoma, 864 Compounding um Chemotherapy of sterile preparations, 899 Calmactin. See Cilansetron preparation, NIOSH guideline for, 911 USP/NF Chapter <797> and, 899 Campath. See Alemtuzumab verbal orders for, 11 Computerized Prescriber Order Entry Campral. See Acamprosate Children decision support tools, 1106 Cancer enoxaparin-induced thrombocytopenia in, and expansion of pharmacokinetic ser- dyspnea in, furosemide (nebulized) for, 204 vices, 184 1040 pain management in, rofecoxib for, 428 and neonatal total parenteral nutrition, epoetin alfa in, once-weekly administra- parenteral medication delivery to, stan- 580 tion, 531 dardized approach for, 433 pediatric-specific decision support, 381 Cancer Chemotherapy Updates Chlorpromazine, oral liquid, sorbitol content Concerta. See Methylphenidate hydrochlo- abarelix, 628 of, 225 ride bevacizumab, 747 Chlorpropamide (Diabinase), warning relat- Congestive heart failure, thiazolidinedione- cetuximab, 750 ed to, 489 induced, 624 cyclophosphamide and fludarabine with Choriogonadotropin alfa (Ovidrel), 72, 174 Conivaptan (Vaprisol), 576, 690, 797, 889, or without rituximab (CF + R) for Chronic lymphocytic leukemia, cyclophos- 1096, 1097, 1200 chronic lymphocytic leukemia or non- phamide and fludarabine with or with- Continuing Education Quiz Hodgkin's lymphoma, 26 out rituximab for, 26 on acamprosate, 1186 EDAP regimen for multiple myeloma, 216 Cialis. See Tadalafil on botulism immune globulin intravenous, ibritumomab, 126 Cilansetron (Calmactin), 889, 1097, 1200 475 intravesical gemcitabine for bladder can- Cilomilast (Ariflo), 73, 175, 268, 370, 484, on cinacalcet hydrochloride, 678 con 1135 575, 688, 794, 886, 1094, 1197 on daptomycin, 161 intravesical mitomycin for bladder cancer, Cimetidine (Tagamet), oral liquid, sorbitol on ezetimibe/simvastatin,. 1086 1031 content of, 225 on intravenous N-acetylcysteine, 568 melphalan and prednisone (MP) regimen Cinacalcet (Sensipar), 478, 573, 678, 686, on memantine, 261 for multiple myeloma, 320 792 on 8m7o7r phine sulfate, liposomal injection, methotrexate, vinblastine, doxorubicin, review of, 666 and cisplatin (MVAC) regimen for Cipro. See Ciprofloxacin i on risperidone long-acting injection, 361 urothelial tumors, 836 Ciprofloxacin (Cipro), warning related to, on rosuvastatin calcium, 52 pemetrexed, 629 578 on USP/NF Chapter <797>, 918 thalidomide and dexamethasone (TD) reg- Cisplatin (Platinol, Platinol-AQ). See Etopo- Contrast media, intrathecal injection of, imen for multiple myeloma, 526 side, dexamethasone, cytarabine, cis- fatality with, 109 tositumomab, 127 platin (EDAP) regimen Controlled substances, diversion, detection vincristine, doxorubicin and dexametha- Citalopram (Celexa) of, 868 sone (VAD) regimen for multiple discontinuation, premature ejaculation Cordarone. See Amiodarone myéoma, 418 after, 113 Correctional facilities, health care and phar- Cancidas. See Caspofungin hepatotoxicity of, 730 macy in, 896, 1211 Candesartan cilexetil (Atacand), 885, 1093 warning related to, 578, 800, 893 Corticosteroid Capsaicin. See Zostrix Clarinex Syrup. See Desloratadine for critically ill patients, 116 Carac. See Fluorouracil cream Claritin Hives Relief. See Loratadine inhaled, myopathy due to, 404 Carbamazepine (Tegretol) Climara. See Estradiol transdermal system Cost containment, and pharmacy services in hepatic monitoring with, 597 Climara Pro. See Estradiol/levonorgestrel low-income family practice clinic, 346 oral liquid, sorbitol content of, 225 Clindamycin (Actiza), 487, 576, 690, 797, Costs and cost analysis Carbidopa/levodopa (Parcopa), 1089, 1192 889, 1097, 1200 for adverse drug reaction, 648 Cardiomyopathy, ephedra-associated, 313 Clinimix E-Sulfite Free Injection. See Amino for exogenous surfactant, 338 Cardiovascular disease, C-reactive protein as acids with electrolytes in dextrose with for pharmacy services in low-income fami- marker for, 735 calcium ly practice clinic, 346 Carpuject syringe Clinimix—Sulfite Free. See Amino acids with Cough, omeprazole-induced, 15 mix-ups with, 202 dextrose C-reactive protein, as marker for cardiovas- tampering with, 203 Clinoril. See Sulindac cular disease, 735 1214 Volume a3, December 2004 _ Index to Volume 38 Crestor. See Rosuvastatin calcium Depression, sotalol-induced, 830 Dyspnea Critical Care Therapeutics, corticosteroids in, Desloratadine (Clarinex Syrup), 1093, 1193 in cancer patients, furosemide (nebulized 116 Desmopressin acetate (DDAVP for, 1040 Crixivan. See Indinavir Injection/Nasal Spray/Rhinal nebulized opioids for, 920 Cromolyn sodium (Intal HFA), 72, 175, 268, Tube/Tablets), warning related to, 372 E 370, 484, 575, 688, 794, 886, 1094, Desyrel. See Trazodone 1197 Dexamethasone. See Etoposide, dexametha- Eating disorder, zonisamide for, 752 Cubicin. See Daptomycin sone, cytarabine, cisplatin (EDAP) regi- EDAP regimen. See Etoposide, dexametha- Cuprimine. See Penicillamine men sone, cytarabine, cisplatin (EDAP) regi- Current FDA-Related Drug Information Dextroamphetamine and amphetamine men agents pending FDA approval, 73, 175, (Adderall XR), 73, 175, 268, 370, 487, Editorials. See also Viewpoints 268, 370, 484, 575, 688, 794, 886 575, 688, 796, 886, 1094, 1197 Adverse Event Reporting and Rofecoxib 1094, 1197 Dextrose injections, warning related to, 578 Withdrawal: Are Postmarketing "Dear Health Professional Letters" related Diabetes education, 514 Changes Imminent?, 1138 to safety, 74, 177, 270, 372, 489, 578, Diabetes mellitus, type 2, obese patients Bridging the gap for medication safety: 692, 800, 892, 1100, 1202 with, orlistat for, 37 Medication reconciliation, 724 labeling changes, 74, 177, 270, 372, 489, Diabinase. See Chlorpropamide Diabetes education, 514 578, 692, 800, 892, 1100, 1202 Dialysis, slow low-efficiency, vancomycin IV push guidelines, 396 new dosage forms/strengths, 72, 174, 266, and, 138 Medicare prescription drug discount 369, 483, 574, 687, 793, 885, 1093, Diatrozoate meglumine. See Hypaque cards, 817 1193 Diclofenac (Voltaren), hepatic monitoring New models of accountability, 515 new drugs approved, 70, 172, 264, 364, with, 598 "One small step": The Food and Drug 478, 572, 683, 786, 880, 1089, 1192 Digoxin, ginseng and, interactions of, 149 Administration and pharmacogenomic new indications approved, 72, 174, 266, Diovan. See Valsartan data, 200 369, 483, 574, 687, 793, 885, 1093, Diphenoxylate hydrochloride/atropine sul- Parachutes and evidence-based medicine, 1194 fate, oral liquid, sorbitol content of, 618 Cyclophosphamide (Cytoxan), new formula- 225 Peer Review: Personal Continuous Quality tion of, 1021 Divalproex sodium (Depakote ER), 72 Improvement, 8 Cyclophosphamide and fludarabine, with or hyperammonemia with, 1025 Postgraduate Pharmacy Programs: Invest- without rituximab (CF + R), for chron- Dobutamine, eosinophilia caused by, 524 ment in the Future, 1017 ic lymphocytic leukemia or non- Docetaxel (Taxotere), 794, 885, 1093, 1194 A Sense of History, 105 Hodgkin's lymphoma, 26 labeling, and concentration confusion, 728 Webographies: Guiding patient use of the Cyclosporine (Restasis), St. John's wort and, Domperidone, warning related to, 800 Internet for health care information, interactions of, 149 Donepezil (Aricept), 176, 269, 371, 488, 306 Cylert. See Pemoline 576, 690, 797, 889, 1097, 1200 Education and training Cymbalta. See Duloxetine Dopram. See Doxapram hydrochloride postgraduate pharmacy programs for, Cytarabine (DepoCyt). See also Etoposide, Doxapram hydrochloride (Dopram), warning 1017 dexamethasone, cytarabine, cisplatin related to, 801 Efalizumab (Raptiva), 70, 1 (EDAP) regimen Doxazosin, for benign prostatic hyperplasia, Efaproxiral (Excelar), 487, 5 warning related to, 279 4f7o rmulary conversion to terazosin for, Efavirenz (Sustiva) Cytotoxic agents, preparation, NIOSH hepatic monitoring with, 601 guideline for, 911 Doxercalciferol (Hectorol), warning related warning related to, 1202 Cytoxan. See Cyclophosphamide to, 801 Effexor. See Venlafaxine Doxycycline, and intracranial hypertension, Effexor XR. See Venlafaxine D 827 Efudex. See Fluorouracil; Fluorouracil cream Danaparoid Droperidol (Inapsine), 73 Elderly dosage and administration of, 410 Drug diversion, detection of, 868 adverse drug events in, in ambulatory for heparin-induced thrombocytopenia, Drug interactions care, 24 413 and enteral feeding, 84, 225 aminoglycosides for, once-daily adminis- Danshen, and warfarin, interactions of, 149 with herbals, 149 tration of, 238 Dapsone, hepatic monitoring with, 601 preventable, 648 appropriate medication use in, 294 Daptomycin (Cubicin), 71, 168, 173 Drug names, nonproprietary and proposed, drug regimen review for, 23, 210 review of, 161 under consideration by USAN Council, potentially inappropriate drugs for, identi- Daraprim. See Pyrimethamine 821, 1144 fication of, 210 Darbepoetin alfa, for chronic hemodialysis Drug regimen review, for geriatric patients, systolic hypertension in, treatment of, 212 patients, conversion from erythropoi- 23, 210 Eloxatin. See Oxaliplatin tin alfa to, 333 Drug Reviews from The Formulary (Contin- Emsam Patch. See Selegiline Darifenacin (Enablex), 73, 175, 268, 370, uing Education Series) Enablex. See Darifenacin 487, 575, 688, 794, 886, 1094, 1197 botulism immune globulin intravenous, Enbrel. See Etanercept Data warehouse, in monitoring simvastatin human, 470 Enjuvia. See Estrogens, conjugated tablet-splitting initiative, 758 cinacalcet hydrochloride, 666 Enoxaparin, thrombocytopenia with, in Daypro. See Oxaprozin daptomycin, 161 child, 204 DDAVP Injection/Nasal Spray/Rhinal ezetimibe/simvastatin, 1076 Entecavir, 1198 Tube/Tablets. See Desmopressin acetate intravenous N-aceiylcysteine, 564 Enteral feeding Declomycin. See Demeclocycline memantine, 254 clogged feeding tubes in, 84, 225 Delestrogen. See Estradiol valerate’ injection morphine sulfate liposomal injection, 871 compatibility with drug solutions, 84, 225 Delirium, acute, after hepatitis A vaccine, 14 olanzapine for injection (intramuscular), and drug interactions, 84, 225 Demeclocycline (Declomycin), warning | 776 drug therapy with, 84 related to, 489 risperidone long-acting injection, 353 administration methods, 225 Dementia rosuvastatin calcium, 52 dosage form selection, 225 agitation in, olanzapine for, 776 Drug solutions, and enteral feeding, 84 guidelines for, 225 memantine for, 254 Ductus arteriosus, patent, ibuprofen therapy methods of, 225 Depakene. See Valproic acid for, 390 Entereg. See Alvimopan Depakote. See Valproic acid Duloxetine (Cymbalta), 1089, 1093, 1192, Eosinophilia, dobutamine-induced, 524 Depakote ER. See Divalproex sodium 1194 Ephedra, cardiomyopathy with, 313 DepoCyt. See Cytarabine Duramorph Injection. See Morphine sulfate Epivir. See Lamivudine DepoDur. See Morphine sulfate, liposomal Dyslipidemia, in HIV-infected (AIDS Eplerenone (Inspra), 72, 174 patients, 1152 1215 Hospital Pharmacy Index to Volume 38 Epoetin alfa Etoricoxib (Arcoxia), 268, 371, 488, 576, Fluticasone/salmeterol (Advair, Advair once-weekly administration, 531 688, 690, 797, 889, 1097, 1200 Diskus), 72, 174, 266, 687, 794 and pure red cell aplasia, 1152 Eulexin. See Flutamide warning related to, 76, 372 Eptifibatide, versus abciximab, in percuta- Everolimus (Certican), 73, 175, 268, 370, Fluvastatin (Lescol, Lescol XL) neous coronary intervention, 661 487, 575, 688, 796, 886, 1096, 1197 dosage and administration of, 52 Epzicom. See L amivudine/abacavir sulfate Evidence-based medicine, 618 hepatic monitoring with, 595 Erbitux. See Cetuximab in pharmacy benefit management, 272 Fluvoxamine (Luvox), warning related to, Erlotinib (Tarceva), 370, 488, 576, 690, 797, Exanta. See Ximelagatran 578 889, 1097, 1200 Excelar. See Efaproxiral Follitropin alfa/beta (Gonal-F RFF Pen), 793, Ertaczo. See Sertaconazole nitrate Exenatide, 889, 1097, 1200 885 Erythropoietin alfa, for chronic hemodialysis Exendin-4, synthetic. See Exenatide Fondaparinux sodium (Arixtra), 794, 885 patients, conversion to darbepoetin alfa Extravan. See Travoprost/timolol warning related to, 893 from, 333 Ezetimibe (Zetia), with statins, myopathy Food and Drug Administration (FDA) Escitalopram oxalate (Lexapro), 174, 266, caused by, 524 and direct-to-consumer advertising of pre- 369 Ezetimibe/simvastatin (Vytorin), 1089, 1193 scription drugs, 1058 adverse effects and side effects of, sexual, review of, 1076 and labeling of low-density polyethylene 113 fpc ee: containers, 620 warning related to, 489, 578, 801, 893 F and labeling of oral iron products, 109 Esomeprazole (Nexium), 370, 488, 576, 690, Famotidine (Pepcid, Pepcid AC-Maxifoum and pharmacogenomic data, 200 797, 889, 1097, 1194, 1200 Strength), 71 Foradil Certihaler. See Formoterol Essential tremor, topiramate therapy for, 772 long QT syndrome and QT prolongation Formoterol (Foradil Certihaler), 73, 175, Estazolam (ProSom), warning related to, with, 732 268, 370, 487, 575, 688, 796, 886, 1100 Fansidar. See Sulfadoxine/pyrimethamine 1096, 1197 Estorra. See Eszopiclone Fatigue, multiple sclerosis-related, modafinil Formulary Estradiol (Alora, Estrace, Estrace VR, for, 329 advances in (future directions for), 1102 Menostar, Vivelle, Vivelle-Dot, Estro- Fazaclo. See Clozapine drugs considered for, safety-focused phar- Gel), 74, 176, 269, 367, 371, 483, Felbamate (Felbatol), hepatic monitoring macy and therapeutics monographs for, 488, 574, 686, 885. See also 17-Beta- with, 597 653 estradiol Felbatol. See Felbamate historical perspective on, 1102 warning related to, 372, 490 Feldene. See Piroxicam prescription drug benefit, 1102 Estradiol/drospirenone (Angeliq), 1094, 1197 Femara. See Letrozole Fortamet. See Metformin Estradiol/levonorgestrel (Climara Pro), 70, Femhrt. See Norethindrone/ethiny] estradiol Fosamax. See Alendronate 173, 265, 368 Fenofibrate (Tricor), hepatic monitoring Fosamprenavir (Lexiva), 70, 173, 265 Estradiol/norethindrone acetate transdermal with, 596 Fosinopril (Monopril), warning related to, system (CombiPatch), warning related Fentanyl, nebulized, for management of dys- 270 to, 1100 pnea, 920 Fosinopril/hydrochlorothiazide (Monopril- Estradiol/norgestimate (Prefest), warning FerInSol. See Ferrous sulfate HCT), warning related to, 270 related to, 490 Ferric (1177) hexacyanoferrate(II) (Radiogar- Fulvicin P/G. See Griseofulvin Estradiol transdermal system (Climara, dase), 70, 173, 265 Furosemide Menostar), 885, 1094 Ferrous sulfate (FerInSol), oral liquid, sor- nebulized, for dyspnea in cancer patients, warning related to, 490 bitol content of, 225 1040 Estradiol valerate injection (Delestrogen), Ferumoxtran-10 (Combidex), 1197 oral liquid, sorbitol content of, 225 warning related to, 490 Fever, amifostine-induced, 207 G Estrasorb. See 17-Beta-estradiol Fexofenadine/pseudoephedrine (Allegra-D), EstroGel. See Estradiol 370, 488, 577, 690, 797, 890, 1097, Gabapentin, for chemotherapy-induced Estrogens 1200 nausea, 34 conjugated, USP (Premarin Injection), Filgrastim. See Neupogen Galantamine (Reminyl), and Amaryl, confu- warning related to, 800 Finasteride (Proscar), 687, 794 sion of, 1022 conjugated (Cenestin), warning related to, error-prone unit-dose packages, 726 Gamunex. See Immune globulin intravenous 490 Fingernails, clubbing and discoloration of, th (human) conjugated (Enjuvia), 683, 793 angiotensin II receptor blockers, 525 Gatifloxacin (Tequin, Zymar), seizures with, conjugated (Premarin, Premarin Vaginal Fire hazard, flammable products and, 402, 207 Cream), warning related to, 800 1143 Gaviscon. See Aluminum hydroxide/magne- conjugated/medroxyprogesterone acetate Flonase. See Fluticasone propionate sium carbonate (Prempro, Premphase), warning related Flovent Aerosol. See Fluticasone propionate Gemcitabine (Gemzar), 794, 885 to, 800 Flovent Rotadisk. See Fluticasone propionate intravesical, for bladder cancer, 1153 Eszopiclone (Estorra), 484, 575, 688, 796, Floxin. See Ofloxacin off-label uses, 499 886, 1096, 1197 Fludara. See Fludarabine Gemfibrozil (Lopid) Etanercept (Enbrel), 72, 174, 687, 794, 885, Fludarabine (Fludara). See also Cyclophos- hepatic monitoring with, 596 1193 phamide and fludarabine rhabdomyolysis and renal failure with, warning related to, 270 warning related to, 74 208 Ethambutol (Myambutol), warning related Fluoroquinolones Gemtuzumab (Mylotarg), hepatic monitoring to, 578 contraindications to, in myasthenia gravis, with, 602 Ethinyl estradiol/drosperidone (Yasmin), 176, 828 Gemzar. See Gemcitabine 371, 488, 576, 690, 797, 889, 1097, and enteral feeding, 225 Genasense. See Oblimersen sodium 1200 seizures with, 207 Generic drugs, allergy to, 830 Ethosuximide (Zarontin), hepatic monitoring Fluorouracil cream (Carac, Efudex), warning Genotropin. See Somatropin with, 597 related to, 490, 1100 Gentamicin, for elderly, once-daily adminis- Ethotoin (Peganone) Fluoxetine (Prozac), warning related to, 578, tration of, 238 hepatic monitoring with, 597 1202 Geodon. See Ziprasidone warning related to, 177 Flutamide (Eulexin), hepatic monitoring Geriatric Therapeutics Ethyl chloride spray, fire hazard with, 402, with, 602 adverse drug events in ambulatory older 1143 Fluticasone, inhaled, myopathy due to, 404 adults, 24 Ethyol. See Amifostine Fluticasone propionate (Flovent Rotadisk, Beers List updates, 210 Etoposide, dexamethasone, cytarabine, cis- Flovent Aerosol, Flonase), warning drug regimen review, 23, 210 platin (EDAP) regimen, for multiple related to, 270, 578 treatment of systolic hypertension, 210 myeloma, 216 Ginseng, and digoxin, interactions of, 149 1216 Volume 39, December 2004 Index to Volume 38 Gleevec. See Imatinib mesylate Hydrochlorothiazide/losartan potassium Institute for Safe Medication Practices. See Glimepiride (Amaryl), and Reminyl, confu- (Hyzaar), 1094, 1194 also ISMP Adverse Drug Reactions; sion of, 1021 Hydrocodone bitartrate/acetaminophen ISMP Medication Error Report Analy- Glucophage. See Metformin (Hycet), 786, 880 Sis Glucophage XR. See Metformin Hydrocodone bitartrate/ibuprofen (Reprex- tenth anniversary = 619 Glycoprotein Ib/1177a inhibitors, in revas- ain), 786, 880, 1090 Insulin detemir, 73, 175, 268, 370, 487 cularization protection, 661 Hydrocortisone, seizures caused by, 314 688, 796, 886, aa ] 197 Goid, oral (Ridaura), hepatic monitoring Hydromorphone, and morphine, mix-ups, Insulin glulisine (Apidra), 572, 686, 7 with, 598 risk of, 818 Intal HFA. See Cromolyn sodium Gonal-F RFF Pen. See Follitropin alfa/beta Hydromorphone hydrochloride (Palladone), Interferon, and pure red cell — 1 Griseofulvin (Fulvicin P/G), hepatic monitor- 1192 Interferon-beta-1b (Betaseron), 72, 17 ing with, 601 Hylaform. See Hyaluronic acid Internet Growth hormone, human, recombinant, for Hypaque (diatrozoate meglumine), and direct-to-consumer advertising on, 1058 HIV-related lipodystrophy, 222 Omnipaque 300 (iohexal), mix-up of, patient use of, for health care information, Guaifenesin (Mucinex), and Mucomyst, con- 109 306 fusion of, 820 Hyperammonemia, with valproic acid, 1025 Intracranial hypertension, doxycycline and, Guaifenesin/dextromethorphan HBr Hyperkalemia 827 (Mucinex DM), 793, 885 adult, sodium polystyrene sulfonate for, Intralipid. See Intravenous fat emulsion H dosing guidelines for, 765 Intravenous (IV) drugs, anti-infective, con- in hemodialysis patients, 144 version to oral administration, 1069 Haemophilus influenzae, antibiotic resistance Hyperosmolality, of oral drug solutions, and Intravenous fat emulsion (Intralipid), warn- in, 1050 enteral feeding, 84 ing related to, 801 Health care information, Internet as source Hyperparathyroidism, cinacalcet hydrochlo- intrinsa. See Testosterone of, 306 ride for, 666, 678 In-111 Zevalin. See Ibritumomab Heceptin. See Trastuzumab Hypersensitivity syndrome, with valproic lodine-131 tositumomab. See Tositumomab Hectorol. See Doxercalciferol acid, 524 Iohexal. See Omnipaque 300 Helicobacter pylori, pharmacist-managed Hypertension, 592 Iron, oral, labeling of, 109 treatment of, long-term outcomes of, systolic, in elderly, treatment of, 210 Iron sucrose injection (Venofer), warning 1165 venlafaxine and, 114 related to, 76 Hemodialysis Hyponatremia Irritable bowel syndrome, medications for, beta-blockers and, 144 heparin-related, 314 adverse effects and side effects of, 1026 chronic, conversion from erythropoietin paroxetine-induced, 314 ISMP Adverse Drug Reactions alfa to darbepoetin alfa for, 333 Hyzaar. See Hydrochlorothiazide/losartan acute delirium after hepatitis A vaccine, Hemoglobinuria, ribavirin-induced, 525 potassium 14 Heparin acute ischemic colitis caused by anaphy- alternatives to, 410 lactic reaction, 730 hyponatremia caused by, 314 Ibandronate sodium (Boniva), 97, 890, ADR reports, call for, 856 thrombocytopenia induced by 1097, 1200 allergy to generics, 830 complications of, 408 Ibritumomab (In-111 Zevalin, Y-90 Zevalin), alopecia areata with inf liximab, 1026 diagnosis of, 408 126 amifostine-induced fever,2 07 pathophysiology of, 408 Ibuprofen anaphylaxis, 312 terminology for, 408 oral liquid, sorbitol content of, 225 anorgasmia with bupropion, 828 treatment of, 408 for patent ductus arteriosus, 390 anthelmintic-related ADRs, 407 warfarin-induced skin necrosis and gan- lloprost (Ventavis), 889, 1097, 1201 antipsychotics and sudden cardiac death, grene during, 207 Imatinib mesylate (Gleevec), 174, 266, 369 828 HepatAmine. See Amino acid 8% injection hepatic monitoring with, 602 atorvastatin-induced poly neuropathy, 1 Hepatitis pulmonary alveolar proteinosis with, 114 cardiomyopathy with ephedra, 313 cetirizine-induced, 1149 beeaiaicd (Aldara), 484, 575, 687 caspofungin-induced thrombocytopenia, montelukast-induced, 522 Immune globulin (human), intravenous 1148 Hepatitis A vaccine, acute delirium after, 14 (Octagam), 786, 884 cetirizine-induced recurrent hepatitis, 1149 Hepatocellular carcinoma, superselective Immune globulin intravenous (human) clopidogrel-induced thrombotic thrombo- transcatheter arterial chemoemboliza- (Gamunex), 71 cytopenic purpura, 627 tion emulsion for, 864 Immunization, hospital screening of patients CNS effects of alendronate, 730 Hepatotoxicity, of citalopram, 730 for, 1142 colonic ischemia with naratriptan, 1026 Herbal medicine, drug interactions with, 149 Imuran. See Azathioprine dobutamine-induced eosinophilia, 524 History, organizational, documentation of, Indpsine. See Droperidol doxycycline and intracranial hypertension, 105 Inderal LA. See Propranolol hydrochloride 827 Histrelin (Vantas), 176, 269, 371, 488, 577 Indigent care, and pharmacy services, 346 drug reaction reviews, 1152 690, 797, 890, 1097, 1200 Indinavir (Crixivan) enoxaparin-induced thrombocytopenia in HIV-infected (AIDS) patients hepatic monitoring with, 601 child, 204 lipid levels in, monitoring, 1152 warning related to, 893 ephedra-related cardiomyopathy, 313 lipodystrophy in, human growth hormone Indiplon, 1198 epoetin and pure red cell aplasia, 1152 + (recombinant) for, 222 Indomethacin (Indocin), oral liquid, sorbitol ezetimibe and statin-associated myopathy, trimethoprim-sulfamethoxazole (TMP- content of, 225 524 SMX) for, adverse effects and side Infants, botulism immune globulin intra- fingernail clubbing and discoloration with effects of, 113 venous for, 470, 475 angiotensin II receptor blockers, 525 Hot flashes, 898 Infliximab (Remicade), 1194 fluoroquinolone-related seizures, 207 paroxetine for, 130 alopecia areata with, 1026 fluoroquinolones contraindicated in myas- Humira. See Adalimumab warning related to, 1100, 1202 thenia gravis, 828 Hyaluronan (Orthovisc), 369, 484, 575 Infumorph. See Morphine sulfate heparin-induced hyponatremia, 314 Hyaluronic acid (Hylaform, Orthovisc, Infusion pump hepatitis A vaccine, acute delirium after, Restylane), 73, 172, 175, 265, 268, programming, and medication errors, 460 14 368, 370, 483, 487, 575, 576, 683, smart, and patient safety, 460 hepatotoxicity of citalopram, 730 688, 792, 796, 880, 886, 1096, 1197 Infusions, continuous, computerized pre- hydrocortisone-related seizures, 314 Hycet. See Hydrocodone bitartrate/aceta- scriber order entry for, 1106 hyperammonemia with valproic acid, minophen Inspra. See Eplerenone 1025 hypertensive crisis with venlafaxine, 114 Hospital Pharmacy _ 1217 Index to Volume 38 imatinib mesylate and pulmonary alveolar hospital screening of patients for immu- formulary's list of drugs, 81 proteinosis, 114 nization, 1142 high-risk/high-alert drug storage, 285 interferon and pure red cell aplasia, 1152 intrathecal ionic contrast media, fatality IV admixtures, 278, 279 irritable bowel syndrome treatment and, with, 109 labeling requirements, 278, 280 1026 Kayexalate therapy, mers of, 622 look-alike and sound-alike drugs, 82, 83 isotretinoin and thrombocytopenia, 16 Keppra (levetiracetam) and Kaletra magnesium sulfate 50%, storage of, 82 levetiracetam behavioral side effects, 15 (lopinavir/ritonavir) mix-ups, 12 medication monitoring, 81 linezolid-induced neuropathy, 407 Kineret drug information, errata in, 403 medications brought ti home, 80, 83, long QT syndrome and QT prolongation labeling of low-density polyethylene plas- 285 with famotidine, 732 tic containers, 310, 620 monitoring new medications, 284 methemoglobinemia with benzocaine labeling of oral iron products, 109 multidose pediatric oral liquid antibiotics, products, 830 lansoprazole delayed-release orally disinte- 280 montelukast-induced hepatitis, 522 grating tablets, absorption of, 623 night cabinet stock, 282 montelukast-induced urticaria, 729 lidocaine added to IV potassium solutions, nonformulary medication, 80, 81 myopathy due to inhaled corticosteroid, 308 on-call pharmacist, 282 404 medication history, verification, 12 pain management standards, 79 neuroleptic malignant syndrome with metronidazole and metformin, confusion patient assistance programs, 78 paroxetine and olanzapine, 208 of, 1140 PRN doses of IV drugs for pedjatric neutropenia related to morphine-hydromorphone mix-ups, risk patients, 278 piperacillin/tazobactam (Zosyn), 114 of, 818 refrigerator temperatures, 79 omeprazole-induced intractable cough, 15 Mucomyst and Mucinex, confusion of, sample drug documentation, 80 pancreatitis due to ACE inhibitor, 1149 820 storage of concentrated electrolytes, 81, paroxetine-induced hyponatremia, 314 Neumega, Neulasta, and Neupogen, con- 82 photosensitivity reactions, review on, 732 fusion of, 519 syringes, drawing up, 278 polyneuropathy with atorvastatin, 16 new formulation of Cytoxan, 1021 transcription of medication orders by unit premature ejaculation after discontinua- nonproprietary and proposed drug names secretaries, 79 tion of SSRI, 113 under consideration by USAN Council, transfer of medications, 79 protease inhibitors and cardiovascular 821, 1144 unit-dose medications, 280, 281 risk, 1152 oral syringes, 623 vaccine labeling, 280 pulmonary alveolar proteinosis with ima- pneumococcal vaccine administration rate, verbal orders, 79 tinib mesylate, 114 1142 weight and height data, 80 pulmonary edema with Cox-2 inhibitor, potassium chloride errors, fatalities with, and USP/NF Chapter <797>, 899 730 S19 K quetiapine and pancreatitis, 627 Reminyl and Amaryl, confusion of, 1022 rhabdomyolysis and renal failure with robotics and packaging error, 1021 Kaletra. See Lopinavir/ritonavir gemfibrozil, 208 Roxanol error, 310 Kava kava, and alprazolam, interactions of, ribavirin-induced hemoglobinuria, 525 soy allergy, 1141 149 riluzole-induced neutropenia, 626 tall man lettering on labels, 202 Kayexalate. See Sodium polystyrene sul- seizure due to fluoroquinolone, 207 Tamiflu label, 203 fonate powder seizure due to hydrocortisone, 314 two-identifier rule, application of, 728 Keppra. See Levetiracetam sotalol-induced depression, 830 unit-dose packages, error-prone, 726 Ketoconazole (Nizoral), hepatic monitoring SSRI-related transient ischemic attacks, Uroxatral and Oxytrol, confusion of, with, 602 406 1021 Kidney disease. See Renal failure statin-related cognitive impairment, 112 Uroxatral and Roxanol, confusion of, Kineret. See Anakinra tardive dyskinesia, review on, 732 1021 L tenofovir nephrotoxicity, 406 Zostrix cream confused with Zovirax terminology for ADRs, 624 cream, 11 Labeling thiazolidinedione-induced congestive heart Isoniazid (Nydrazid), hepatic monitoring commas in doses/strengths on, 202 failure, 624 with, 601 docetaxel, and concentration confusion, thrombocytopenia with isotretinoin, 16 Isotretinoin (Accutane) 728 thrombocytopenia with quinine and quini- thrombocytopenia related to, 16 of low-density polyethylene plastic con- dine, 313 warning related to, 76 tainers, 310, 620 topiramate and ocular side effects, 15 Istalol. See Timolol maleate of oral iron products, 109 transfer between acute and long-term care Itraconazole (Sporanox) tall man lettering for, 202 facilities and ADEs, 407 hepatic monitoring with, 602 Tamiflu, 203 trimethoprim-sulfamethoxazole in AIDS warning related to, 177 Lamictal. See Lamotrigine patient, 113 IV push medications, guidelines for, 396 Lamisil. See Terbinafine valproic acid-related hypersensitivity syn- Lamivudine (Epivir), hepatic monitoring J drome, 524 with, 601 visual side effects of pegylated interferon, Japan, pharmaceutical care in, 94 Lamivudine/abacavir sulfate (Epzicom), 1026 Joint Commission on Accreditation of 1090, 1193 warfarin-induced skin necrosis and gan- Healthcare Organizations (JCAHO) Lamotrigine (Lamictal), 266, 369, 484 grene during heparin-induced thrombo- medication management standards for Lansoprazole (Prevacid), 885, 1093, 1094, cytopenia, 207 2004, 78, 278 1193 ISMP Medication Error Report Analysis access to pharmacy after hours, 282, 284 delayed-release orally disintegrating acetylcysteine dosage forms, confusion after-hours dispensing, 282, 284 tablets, absorption of, 623 between, 1020 anesthetic agents, 78 Lansoprazole/naproxen (Prevacid Napra- Actonel and Actos, confusion of, 820 application of, 285 PAC), 70, 173, 265, 368 Carpuject syringe mix-ups, 203 automatic stop orders, 79 Lariam. See Mefloquine Carpuject syringe tampering, 203 definition of "readily accessible" informa- Lasofoxifene, 1198 chemotherapy orders, 11 tion, 80 Laxatives, enteral administration of, 225 commas in doses/strengths on dispensing discontinued medications, 80 Learned intermediary rule, 1058 label, 202 documentation requirements, 80 Leflunomide (Arava) docetaxel labeling, and concentration con- drug information for nurses, 79 hepatic monitoring with, 601 fusion, 728 emergency medication security, 83 warning related to, 76 flammable products, 402, 1143 emergent administration of IV admixtures, Legal considerations 279 with direct-to-consumer advertising of floor stock, 281 prescription drugs, 1058 1218 Volume 39, December 2004 Index to Volume 38 learned intermediary rule, 1058 Low-density polyethylene plastic containers, Metronidazole with USP/NF Chapter <797>, 899 labeling of, 310, 620 and metformin, confusion of, 1140 warning dilution cases, 1058 Lucinactant (Surfaxin), 576, 691, 798, 890, Mevacor. See Lovastatin Lepirudin (Refludan) 1097, 1201 Micardis. See Telmisartan dosage and administration of, 410 Lupron. See Leuprolide acetate Midazolam, continuous infusion, computer- for heparin-induced thrombocytopenia, Luvox. See Fluvoxamine ized prescriber order entry for, 1106 410 Lyrica. See Pregabalin Mirtazapine (Remeron), warning related to, Lescol. See Fluvastatin $79, 1100 Lescol XL. See Fluvastatin Mitomycin, intravesical, for bladder cancer, Letrozole (Femara), 690, 797, 890, 1097, Maalox. See Aluminum hydroxide/ 1031 1201 magnesium hydroxide Mobic. See Meloxicam Letters to the Editor, IV potassium infusions, Macugen. See Pegaptanib sodium Modafinil (Provigil), 369, 484 516 Managed Care Pharmacist Modafinil, for multiple sclerosis-related Leuprolide acetate (Lupron), warning related justification-based pharmacy benefits, 272 fatigue, 329 to, 578 and prescription drug benefit formularies, Moexipril (Univasc), warning related to, 270 Levalbuterol (Xopenex HFA), 690, 797, 890, 1102 Moexipril/hydrochlorothiazide (Uniretic), 1097, 1201 prior authorization programs, 493 warning related to, 270 Levaquin. See Levofloxacin Margibo. See Vincristine, liposomal Mometasone furoate monohydrate (Scent- Levetiracetam (Keppra) Mavik. See Trandolapril Free Nasonex), 1093, 1194 adverse effects and side effects of, behav- Medical news columns, 294 Monopril. See Fosinopril ioral, 15 Medicare prescription drug discount cards, Monopril-HCT. See and Kaletra, confusion of, 12 817 Fosinopril/hydrochlorothiazide warning related to, 76 Medication errors Montelukast (Singulair) Levitra. See Vardenafil accountability for, 515 hepatitis caused by, 522 Levofloxacin (Levaquin), 72, 174, 885 and adverse drug reactions, 648 packaging, error-prone, 726 Levonorgestrel (Plan B), 175, 268, 370, 487, costs of, 648 urticaria caused by, 729 576 smart infusion pumps and, 460 Morphine Levonorgestrel/ethinyl estradiol (Seasonale), voice-mail-based reporting system for, 857 concentrated solution (Roxanol) 71, 173. See also Ethiny! estradiol/lev- Medication history, verification of, 12 error with, 310 onorgestrel Medication process, quality of, and Uroxatral, confusion of, 1021 Levothyroxine sodium (Levoxyl), warning pharmacist-technician teams and, 1169 nebulized, for management of dyspnea, related to, 1202 Medication reconciliation, 724 920 Levoxyl. See Levothyroxine sodium Mefloquine (Lariam), warning related to, 76 Morphine (DepoMorphine), and hydromor- Lexapro. See Escitalopram oxalate Megestrol acetate, 1198 phone, mix-ups, risk of, 818 Lexiva. See Fosamprenavir Meloxicam (Mobic), 1094, 1194 Morphine sulfate (Infumorph, Duramorph Lidocaine, added to IV potassium solutions, hepatic monitoring with, 600 Injection) 308, 516 Melphalan and prednisone (MP) regimen, for oral liquid, sorbitol content of, 225 Lidocaine HCL and 5% dextrose injection, aultiple myeloma, 320 warning related to, 893 warning related to, 490 Memantine (Namenda), 71, 173, 261, 265, Morphine sulfate, liposomal (DepoDur), Linezolid (Zyvox), neuropathy caused by, 268, 371, 488, 577, 691, 798, 890, 786, 877, 884 407 1097, 1201 review of, 871 Lipitor. See Atorvastatin review of, 254 Movement disorder, topiramate therapy in, Lipodystrophy, HIV-related, human growth Menactra. See Quadrivalent meningococcal ir yy hormone (recombinant) for, 222 conjugate vaccine Moxifloxacin (Avelox), 794, 885 Liquid medications, enteral administration Meningitis, coccidioidal, treatment of, warning related to, 270 of, 84, 225 amphotericin B stability and, 554 MS-325, 176, 269, 371, 488, 577, 691, 798, Lisinopril (Prinivil, Zestril) Menostar. See Estradiol; Estradiol transder- 890, 1097, 1201 error-prone unit-dose packages, 726 mal system MT 100, 796, 886 warning related to, 578 Mesalamine (Salofalk), 269, 371, 488, 577, MT 300, 73, 175 Lisinopril/hydrochlorothiazide (Prinzide), 798, 890, 1097, 1201 Mucinex. See Guaifenesin warning related to, 579 Metaclopramide hydrochloride/naproxen Mucinex DM. See Guaifenesin/dex- Lithium citrate, oral liquid, sorbitol content sodium. See MT 100 tromethorphan HBr of, 225 Metformin (Fortamet, Riomet, Glucophage, Mucomyst. See Acetylcysteine Liver failure, nefazodone-induced, 696 Glucophage XR), 73, 175, 268, 370, Multiple myeloma Liver function, monitoring, medications 487, 575, 688, 793, 796, 885, 886, EDAP regimen for, 216 requiring, 595 1096, 1197 melphalan and prednisone (MP) regimen LJP 394 (Riquent), 176, 269, 371, 488, 577, and metronidazole, confusion of, 1140 for, 320 690, 7¥7, 890 warning related to, 579, 1100 thalidomide and dexamethasone (TD) reg- Long QT syndrome, with famotidine, 732 Methemoglobinemia, with benzocaine imen for, 526 Lopid. See Gemfibrozil products, 830 vincristine, doxorubicin and dexametha- Lopinavir/ritonavir (Kaletra) Methocarbamol (Robaxin), warning related sone (VAD) regimen for, 418 hepatic monitoring with, 601 to, 893 Myasthenia gravis, 389 and Keppra, confusion of, 12 Methotrexate (Rheumatrex) fluoroquinolones contraindicated in, 828 Loratadine (Claritin Hives Relief), 72, 174, hepatic monitoring with, 598 Mycophenolate sodium (Myfortic), 478, 266 injection, warning related to, 490 574, 686, 793 Lotensin. See Benazepril Methotrexate, vinblastine, doxorubicin, and Myelography, contrast media for, 109 Lotensin HCT. See Benazepril/hydrochloroth- cisplatin (MVAC) regimen, for urothe- Myfortic. See Mycophenolate sodium iazide lial tumors, 836 Mykrox. See Metolazone Loteprednol etabonate/tobramycin (ZyLET), Methsuximide (Celontin), hepatic monitoring Mylotarg. See Gemtuzumab 74, 176, 269, 371, 488, 577, 691, 798, with, 597 Myopathy 890, 1096, 1197 Methylin. See Methylphenidate corticosteroid (inhaled) and, 404 Lotrel. See Amlodipine besylate/benazepril Methy!phenidate (Methylin), 1093, 1194 ezetimibe and statin-associated, 524 hydrochloride Methylphenidate hydrochloride (Concerta), N Lovastatin (Mevacor, Altocor, Altocor 687, 793 Extended-Release Tablets) Metoclopramide (Reglan), warning related Nabumetone (Relafen), hepatic monitoring dosage and administration of, 52 to, 801 with, 600 hepatic monitoring with, 595 Metolazone (Mykrox), warning related to, Namenda. See Memantine warning related to, 177 76 Naprosyn. See Naproxen Hospital Pharmacy 1219 index to Volume 38 = Naprosyn EC. See Naproxen Octagam. See Immune globulin (human), Oxcarbazepine (Trileptal), hepatic monitor- Naproxen (Naprosyn, Naprosyn EC, Aleve, intravenous ing with, 597 Anaprox), hepatic monitoring with, Off-Label Drug Uses Oxybutynin (Oxytrol, Ditropan) 598 epoetin, once-weekly administration, 531 oral liquid, sorbitol content of, 225 Naratriptan (Amerge) furosemide (nebulized) for dyspnea in can- and Uroxatral, confusion of, 1021 colonic ischemia with, 1026 cer patients, 1040 Oxycodone (Remoxyl), 74, 176, 269, 371, warning related to, 270 gabapentin for chemotherapy-induced 488, 577, 691, 798, 890, 1097, 1201 Nasacort HFA. See Triamcinolone acetonide nausea, 34 Oxycodone/aspirin (Percodan, Percodan National Committee for Clinical Laboratory gemcitabine, 499 Demi), warning related to, 1100 Standards (NCCLS), guidelines for human growth hormone (recombinant) for Oxyprim. See Oxypurinol antibiograms, 542 HIV-related lipodystrophy, 222 Oxypurinol (Oxyprim), 688, 886, 1096, National Institute for Occupational Safety modafinil for multiple sclerosis-related 1197 and Health, guideline for preparation fatigue, 329 Oxytrol. See Oxybutynin of chemotherapy and other cytotoxic paroxetine for hot flashes, 130 e agents, 911 promotion of, by manufacturer, 1058 Nausea, chemotherapy-induced, gabapentin rofecoxib for pediatric postoperative pain Packaging, error in, despite robotics, 1021 for, 34 management, 428 Paclitaxel, nanoparticle (Abraxane), 690, Nebivolol, 690, 798, 890, 1097, 1201 sildenafil (topical) for anal fissures, 1160 798, 890, 1097, 1201 Nefazodone (Serzone} sodium bicarbonate for prevention of con- Pain management hepatic monitoring with, 597 trast-induced nephrotoxicity, 854 pediatric, rofecoxib for, 428 liver failure caused by, 696 vancomycin aerosolization, 638 with potassium infusions, lidocaine for, warning related to, 579, 893 zonisamide for binge eating disorder, 752 308, 516 Neonatal! abstinence syndrome, 500 Ofloxacin (Floxin, Floxin Otic Singles), 484, Palivizumab (Synagis), 1093 Neonatal parenteral nutrition, 502 575, 687, 793, 885 computerized prescriber order entry for, computerized order entry in, 580 Olanzapine (Zyprexa), 266, 369, 484, 574, 1106 Neonatal pulmonary hypertension 687 Palladone. See Hydromorphone hydrochlo- phosphodiesterase inhibitors for, 831 for injection (intramuscular), 783 ride sildenafil for, 831 review of, 776 Pancreatitis Nephrotoxicity, contrast-agent-induced, pre- and paroxetine, combined, neuroleptic quetiapine and, 627 vention of, sodium bicarbonate for, malignant syndrome with, 208 ramipril-induced, 1149 854 Olanzapine/fluoxetine (Symbyax), 264, 368, Pantoprazole (Protonix), 574, 687, 793 Neulasta (pegfilgrastim), and Neumega, con- 483 and protamine, confusion of, 403 fusion of, 519 Omeprazole (Zegerid), 792, 884, 1190 Parcopa. See Carbidopa/levodopa Neumega. See Oprelvekin cough caused by, 15 Parenteral drug delivery Neupogen (filgrastim), and Neumega, confu- Omnicef. See Cefdinir to children, standardized approach for, sion of, 519 Omnipaque 300 (iohexal), and Hypaque 433 Neupro. See Rotigotine (Neupro) (diatrozoate meglumine), mix-up of, smart infusion pumps in, 460 Neuroleptic malignant syndrome, with 109 Parenteral nutrition, neonatal, 502 paroxetine and olanzapine, 208 Onco TCS. See Vincristine sulfate liposomal computerized order entry in, 580 Neuromuscular blocking drugs, in pediatrics, injection; Vincristine sulfate liposome Paricalcitol (Zemplar), 794, 885 189 injection Parkinson's disease, memantine for, 254 Neuropathy Opioids, nebulized, for management of dysp- Paroxetine (Paxil, Paxil CR, Pexeva), 72, 174 linezolid-induced, 407 nea, 920 for hot flashes, 130 memantine for, 254 Oprelvekin (Neumega) hyponatremia caused by, 314 Neutropenia and Neulasta, confusion of, 519 and olanzapine, combined, neuroleptic piperacillin-tazobactam and, 114 and Neupogen, confusion of, 519 malignant syndrome with, 208 riluzole-induced, 626 warning related to, 894 transient ischemic attacks due to, 406 Nevirapine (Viramune) Oral dosage forms warning related to, 579, 894, 1202 hepatic monitoring with, 601 of anti-infectives, conversion to, from Patient, two-identifier rule for, 728 warning related to, 372, 490, 894 intravenous, 1069 Patient assistance programs, pharmacy ser- Nexium. See Esomeprazole liquid, sorbitol in, 84, 225 vices and, 346 Niacin (Niaspan), hepatic monitoring with, that should not be crushed, 225 Patient education 596 Oral drug administration about diabetes, 514 Niaspan. See Niacin alternatives to, 225 Internet and, 306 Niferex, labeling of, 109 solutions for, and enteral feeding, 84 PDA interface and, 386 Nizoral. See Ketoconazole Orally disintegrating tablets, absorption of, Paxil. See Paroxetine Non-Hodgkin's lymphoma, cyclophos- 623 Paxil CR. See Paroxetine phamide and fludarabine with or with- Orap. See Pimozide PDA Interface out rituximab for, 26 Orathecin. See Rubitecan backing up, 693 Norethindrone/ethiny] estradiol (Femhrt, Orlistat (Xenical), 174, 266, 369 and barcoding, 386 Ovcon 35), 71, 174, 266 for obese patients with type 2 diabetes data input options, expanding, 802 warning related to, 490 mellitus, 37 and digital imaging, 1206 Norvir. See Ritonavir Orthovisc. See Hyaluronan; Hyaluronic acid and display options, 386 Nursing, satisfaction with pharmacy services, Oseltamivir phosphate (Tamiflu) functionality of PDA in, 90 pharmacist-technician teams and, 1169 labeling of, 203 infrared beaming as clinical practice tool, Nutritional support. See Enteral feeding; Par- warning related to, 271 286 enteral nutrition Osmotic load, of oral drug solutions, and multifunction PDAs, 1206 Nutrition Support Consultant, enteral tube enteral feeding, 84 and patient education, 386 feeding and medication administration, Ovcon 35. See Norethindrone/ethinyl estradi- patient safety, 386 84 ol security considerations, 693 Nydrazid. See Isoniazid Ovidrel. See Choriogonadotropin alfa "thin client" PDA computing for, 587 0 Oxaliplatin (Eloxatin), 266, 369, 484 and voice-operated communications, 386 hepatic monitoring with, 602 and wireless connectivity, 386, 587 Obesity, in type 2 diabetes mellitus, orlistat Oxandrin. See Oxandrolone Pediatric emergency room, pharmacy services for, 37 Oxandrolone (Oxandrin), warning related in, 121 Oblimersen sodium (Genasense), 176, 269, to, 692 Pediatric therapeutics 371, 487, 488, 576, 577, 688, 691, Oxaprozin (Daypro), hepatic monitoring antimicrobial stewardship program for, 796, 798, 890, 1097, 1201 with, 600 development of, 317 1220 Volum3e9 , December 2004 _